Patents by Inventor Mahesh Narayan Keregadde

Mahesh Narayan Keregadde has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230391790
    Abstract: Compounds of formula (I): wherein, R1, R2, R3, R4a, R4b and R5 are described herein, or a stereoisomer, enantiomer or tautomer thereof or mixtures thereof, or a pharmaceutically acceptable salt or solvate thereof, are described herein, as well as other compounds. These compounds are useful in treating inflammation and/or pain. Compositions comprising a compound of the invention are also disclosed, as are methods of using the compounds to treat inflammation and/or pain.
    Type: Application
    Filed: August 21, 2023
    Publication date: December 7, 2023
    Applicant: TARO PHARMACEUTICALS INC.
    Inventors: Curtis HARWIG, Jeremy D. PETTIGREW, Jennifer CROSS, Jeyaprakashnarayanan SEENISAMY, Mahesh Narayan KEREGADDE, Karthikeyan IYANAR
  • Patent number: 11773108
    Abstract: Compounds of formula (1): wherein, R1, R2, R3, R4a, R4b and R5 are described herein, or a stereoisomer, enantiomer or tautomer thereof or mixtures thereof, or a pharmaceutically acceptable salt or solvate thereof, are described herein, as well as other compounds. These compounds are useful in treating inflammation and/or pain. Compositions comprising a compound of the invention are also disclosed, as are methods of using the compounds to treat inflammation and/or pain.
    Type: Grant
    Filed: May 23, 2022
    Date of Patent: October 3, 2023
    Assignee: Taro Pharmaceuticals Inc.
    Inventors: Curtis Harwig, Jeremy D. Pettigrew, Jennifer Cross, Jeyaprakashnarayanan Seenisamy, Mahesh Narayan Keregadde, Karthikeyan Iyanar
  • Publication number: 20230203089
    Abstract: Wherein, R1, R2, R3, R4a, R4b and R5 are described herein, or a stereoisomer, enantiomer or tautomer thereof or mixtures thereof, or a pharmaceutically acceptable salt or solvate thereof, are described herein, as well as other compounds. These compounds are useful in treating inflammation and/or pain. Compositions comprising a compound of the invention are also disclosed, as are methods of using the compounds to treat inflammation and/or pain.
    Type: Application
    Filed: February 17, 2023
    Publication date: June 29, 2023
    Applicant: TARO PHARMACEUTICALS INC.
    Inventors: Curtis HARWIG, Jeremy D. PETTIGREW, Jennifer CROSS, Jeyaprakashnarayanan SEENISAMY, Mahesh Narayan KEREGADDE, Samir Satish KHER, Karthikeyan IYANAR
  • Publication number: 20230002366
    Abstract: Compounds of formula (I) wherein, R1, R2, R3, R4a, R4b and R5 are described herein, or a stereoisomer, enantiomer or tautomer thereof or mixtures thereof, or a pharmaceutically acceptable salt or solvate thereof, are described herein, as well as other compounds. These compounds are useful in treating inflammation and/or pain. Compositions comprising a compound of the invention are also disclosed, as are methods of using the compounds to treat inflammation and/or pain.
    Type: Application
    Filed: August 4, 2022
    Publication date: January 5, 2023
    Applicant: TARO PHARMACEUTICALS INC.
    Inventors: Curtis HARWIG, Jeremy D. PETTIGREW, Jennifer CROSS, Jeyaprakashnarayanan SEENISAMY, Mahesh Narayan KEREGADDE, Samir Satish KHER
  • Publication number: 20220306645
    Abstract: Compounds of formula (1): wherein, R1, R2, R3, R4a, R4b and R5 are described herein, or a stereoisomer, enantiomer or tautomer thereof or mixtures thereof, or a pharmaceutically acceptable salt or solvate thereof, are described herein, as well as other compounds. These compounds are useful in treating inflammation and/or pain. Compositions comprising a compound of the invention are also disclosed, as are methods of using the compounds to treat inflammation and/or pain.
    Type: Application
    Filed: May 23, 2022
    Publication date: September 29, 2022
    Applicant: TARO PHARMACEUTICALS INC.
    Inventors: Curtis HARWIG, Jeremy D. PETTIGREW, Jennifer CROSS, Jeyaprakashnarayanan SEENISAMY, Mahesh Narayan KEREGADDE, Karthikeyan IYANAR
  • Patent number: 11420962
    Abstract: Compounds of formula (I) wherein, R1, R2, R3, R4a, R4b and R5 are described herein, or a stereoisomer, enantiomer or tautomer thereof or mixtures thereof, or a pharmaceutically acceptable salt or solvate thereof, are described herein, as well as other compounds. These compounds are useful in treating inflammation and/or pain. Compositions comprising a compound of the invention are also disclosed, as are methods of using the compounds to treat inflammation and/or pain.
    Type: Grant
    Filed: April 5, 2019
    Date of Patent: August 23, 2022
    Assignee: TARO PHARMACEUTICALS INC.
    Inventors: Curtis Harwig, Jeremy D. Pettigrew, Jennifer Cross, Jeyaprakashnarayanan Seenisamy, Mahesh Narayan Keregadde, Samir Satish Kher
  • Patent number: 11352367
    Abstract: Compounds of formula (I): wherein, R1, R2, R3, R4a, R4b and R5 are described herein, or a stereoisomer, enantiomer or tautomer thereof or mixtures thereof, or a pharmaceutically acceptable salt or solvate thereof, are described herein, as well as other compounds. These compounds are useful in treating inflammation and/or pain. Compositions comprising a compound of the invention are also disclosed, as are methods of using the compounds to treat inflammation and/or pain.
    Type: Grant
    Filed: April 5, 2019
    Date of Patent: June 7, 2022
    Assignee: TARO PHARMACEUTICALS INC.
    Inventors: Curtis Harwig, Jeremy D. Pettigrew, Jennifer Cross, Jeyaprakashnarayanan Seenisamy, Mahesh Narayan Keregadde, Karthikeyan Iyanar
  • Publication number: 20210155615
    Abstract: Compounds of formula (I) wherein, R1, R2, R3, R4a, R4b and R5 are described herein, or a stereoisomer, enantiomer or tautomer thereof or mixtures thereof, or a pharmaceutically acceptable salt or solvate thereof, are described herein, as well as other compounds. These compounds are useful in treating inflammation and/or pain. Compositions comprising a compound of the invention are also disclosed, as are methods of using the compounds to treat inflammation and/or pain.
    Type: Application
    Filed: April 5, 2019
    Publication date: May 27, 2021
    Applicant: AQUINOX PHARMACEUTICALS (CANADA) INC.
    Inventors: Curtis HARWIG, Jeremy D. PETTIGREW, Jennifer CROSS, Jeyaprakashnarayanan SEENISAMY, Mahesh Narayan KEREGADDE, Samir Satish KHER
  • Publication number: 20210032264
    Abstract: Compounds of formula (I): wherein, R1, R2, R3, R4a, R4b and R5 are described herein, or a stereoisomer, enantiomer or tautomer thereof or mixtures thereof, or a pharmaceutically acceptable salt or solvate thereof, are described herein, as well as other compounds. These compounds are useful in treating inflammation and/or pain. Compositions comprising a compound of the invention are also disclosed, as are methods of using the compounds to treat inflammation and/or pain.
    Type: Application
    Filed: April 5, 2019
    Publication date: February 4, 2021
    Applicant: AQUINOX PHARMACEUTICALS (CANADA) INC.
    Inventors: Curtis HARWIG, Jeremy D. PETTIGREW, Jennifer CROSS, Jeyaprakashnarayanan SEENISAMY, Mahesh Narayan KEREGADDE, Karthikeyan IYANAR
  • Publication number: 20210024571
    Abstract: wherein, R1, R2, R3, R4a, R4b and R5 are described herein, or a stereoisomer, enantiomer or tautomer thereof or mixtures thereof, or a pharmaceutically acceptable salt or solvate thereof, are described herein, as well as other compounds. These compounds are useful in treating inflammation and/or pain. Compositions comprising a compound of the invention are also disclosed, as are methods of using the compounds to treat inflammation and/or pain.
    Type: Application
    Filed: April 5, 2019
    Publication date: January 28, 2021
    Applicant: AQUINOX PHARMACEUTICALS (CANADA) INC.
    Inventors: Curtis HARWIG, Jeremy D. PETTIGREW, Jennifer CROSS, Jeyaprakashnarayanan SEENISAMY, Mahesh Narayan KEREGADDE, Samir Satish KHER, Karthikeyan IYANAR
  • Patent number: 10053415
    Abstract: This invention is directed to methods of preparing AQX-1125 having the formula: This invention is also directed to intermediates utilized in the methods of preparing AQX-1125.
    Type: Grant
    Filed: January 20, 2017
    Date of Patent: August 21, 2018
    Assignee: Aquinox Pharmaceuticals (Canada) Inc.
    Inventors: Curtis Harwig, Jeyaprakashnarayanan Seenisamy, Mahesh Narayan Keregadde, Lakshindra Chetia
  • Publication number: 20180086691
    Abstract: This invention is directed to methods of preparing AQX-1125 having the formula: This invention is also directed to intermediates utilized in the methods of preparing AQX-1125.
    Type: Application
    Filed: January 20, 2017
    Publication date: March 29, 2018
    Inventors: Curtis Harwig, Jeyaprakashnarayanan Seenisamy, Mahesh Narayan Keregadde, Lakshindra Chetia
  • Publication number: 20170204048
    Abstract: This invention is directed to methods of preparing AQX-1125 having the formula: This invention is also directed to intermediates utilized in the methods of preparing AQX-1125.
    Type: Application
    Filed: January 20, 2017
    Publication date: July 20, 2017
    Inventors: Curtis Harwig, Jeyaprakashnarayanan Seenisamy, Mahesh Narayan Keregadde, Lakshindra Chetia